Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | decreases expression | ISO | Dennd10 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of FAM45A mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | multiple interactions | ISO | Dennd10 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DENND10 mRNA | CTD | PMID:22206623 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of DENND10 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of DENND10 mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of DENND10 mRNA | CTD | PMID:28628672 | aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of DENND10 mRNA | CTD | PMID:22100608 | antirheumatic drug | increases expression | EXP | | 6480464 | Antirheumatic Agents results in increased expression of DENND10 mRNA | CTD | PMID:24449571 | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of FAM45A mRNA | CTD | PMID:33212167 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of DENND10 mRNA | CTD | PMID:32234424 | bisphenol A | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of DENND10 mRNA | CTD | PMID:28628672 | bisphenol A | increases expression | ISO | Dennd10 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of DENND10 mRNA | CTD | PMID:25181051 and PMID:33296240 | bisphenol A | increases expression | ISO | Dennd10 (Mus musculus) | 6480464 | bisphenol A results in increased expression of DENND10 mRNA | CTD | PMID:21932408 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of DENND10 mRNA | CTD | PMID:29275510 | clozapine | increases expression | ISO | Dennd10 (Rattus norvegicus) | 6480464 | Clozapine results in increased expression of DENND10 mRNA | CTD | PMID:16715494 | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of DENND10 mRNA | CTD | PMID:19549813 | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of DENND10 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of DENND10 mRNA | CTD | PMID:28628672 | dioxygen | decreases expression | EXP | | 6480464 | Oxygen deficiency results in decreased expression of DENND10 mRNA | CTD | PMID:24236059 | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of DENND10 mRNA | CTD | PMID:29803840 | ethanol | affects splicing | ISO | Dennd10 (Mus musculus) | 6480464 | Ethanol affects the splicing of DENND10 mRNA | CTD | PMID:30319688 | flutamide | increases expression | ISO | Dennd10 (Rattus norvegicus) | 6480464 | Flutamide results in increased expression of DENND10 mRNA | CTD | PMID:24136188 | folic acid | multiple interactions | ISO | Dennd10 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DENND10 mRNA | CTD | PMID:22206623 | haloperidol | increases expression | ISO | Dennd10 (Rattus norvegicus) | 6480464 | Haloperidol results in increased expression of DENND10 mRNA | CTD | PMID:16715494 | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of DENND10 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of DENND10 mRNA | CTD | PMID:28628672 | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of DENND10 protein | CTD | PMID:32959892 | nickel atom | decreases expression | EXP | | 6480464 | Nickel results in decreased expression of DENND10 mRNA | CTD | PMID:23195993 | pirinixic acid | increases expression | ISO | Dennd10 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of DENND10 mRNA | CTD | PMID:23811191 | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of DENND10 mRNA | CTD | PMID:23557933 | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of DENND10 mRNA | CTD | PMID:31533062 | thioacetamide | increases expression | ISO | Dennd10 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of DENND10 mRNA | CTD | PMID:34492290 | tributylstannane | increases expression | ISO | Dennd10 (Rattus norvegicus) | 6480464 | tributyltin results in increased expression of DENND10 mRNA | CTD | PMID:31129395 | trichostatin A | affects expression | EXP | | 6480464 | trichostatin A affects the expression of DENND10 mRNA | CTD | PMID:28542535 | triptonide | affects expression | ISO | Dennd10 (Mus musculus) | 6480464 | triptonide affects the expression of DENND10 mRNA | CTD | PMID:33045310 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of DENND10 mRNA | CTD | PMID:23179753 | |